Gabelli Funds LLC trimmed its position in HCA Healthcare Inc (NYSE:HCA) by 34.6% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 70,900 shares of the company’s stock after selling 37,500 shares during the quarter. Gabelli Funds LLC’s holdings in HCA Healthcare were worth $9,864,000 as of its most recent filing with the Securities & Exchange Commission.
Several other hedge funds and other institutional investors have also recently modified their holdings of the stock. Kendall Capital Management increased its stake in shares of HCA Healthcare by 5.2% in the third quarter. Kendall Capital Management now owns 8,250 shares of the company’s stock worth $1,148,000 after buying an additional 405 shares during the period. Motley Fool Asset Management LLC increased its position in HCA Healthcare by 12.5% during the 2nd quarter. Motley Fool Asset Management LLC now owns 3,720 shares of the company’s stock valued at $382,000 after purchasing an additional 412 shares during the period. DNB Asset Management AS increased its position in HCA Healthcare by 1.1% during the 3rd quarter. DNB Asset Management AS now owns 36,357 shares of the company’s stock valued at $5,058,000 after purchasing an additional 413 shares during the period. Banque Pictet & Cie SA increased its position in HCA Healthcare by 0.5% during the 2nd quarter. Banque Pictet & Cie SA now owns 91,929 shares of the company’s stock valued at $9,432,000 after purchasing an additional 480 shares during the period. Finally, Gideon Capital Advisors Inc. increased its position in HCA Healthcare by 14.7% during the 2nd quarter. Gideon Capital Advisors Inc. now owns 4,441 shares of the company’s stock valued at $456,000 after purchasing an additional 569 shares during the period. 70.84% of the stock is currently owned by institutional investors.
A number of brokerages have issued reports on HCA. SunTrust Banks boosted their price objective on shares of HCA Healthcare to $145.00 and gave the company a “buy” rating in a research report on Thursday, July 26th. ValuEngine raised shares of HCA Healthcare from a “hold” rating to a “buy” rating in a research report on Wednesday, July 18th. Credit Suisse Group boosted their price objective on shares of HCA Healthcare from $156.00 to $165.00 and gave the company an “outperform” rating in a research report on Thursday, November 1st. Argus boosted their price objective on shares of HCA Healthcare from $150.00 to $155.00 and gave the company a “buy” rating in a research report on Tuesday, November 6th. Finally, Barclays began coverage on shares of HCA Healthcare in a research report on Tuesday, August 14th. They set an “overweight” rating and a $150.00 price objective on the stock. Two equities research analysts have rated the stock with a sell rating, four have assigned a hold rating and sixteen have assigned a buy rating to the stock. HCA Healthcare currently has an average rating of “Buy” and an average target price of $141.53.
Shares of HCA stock opened at $143.95 on Friday. HCA Healthcare Inc has a 12 month low of $74.26 and a 12 month high of $144.18. The firm has a market cap of $48.74 billion, a PE ratio of 21.84, a price-to-earnings-growth ratio of 1.24 and a beta of 0.48.
HCA Healthcare (NYSE:HCA) last announced its earnings results on Tuesday, October 30th. The company reported $2.16 EPS for the quarter, beating the Zacks’ consensus estimate of $1.93 by $0.23. HCA Healthcare had a net margin of 6.82% and a negative return on equity of 73.71%. The firm had revenue of $11.45 billion for the quarter, compared to analysts’ expectations of $11.29 billion. During the same quarter in the previous year, the business posted $1.13 EPS. The company’s quarterly revenue was up 7.1% on a year-over-year basis. On average, sell-side analysts forecast that HCA Healthcare Inc will post 9.35 earnings per share for the current year.
The firm also recently announced a quarterly dividend, which will be paid on Friday, December 28th. Stockholders of record on Monday, December 3rd will be issued a dividend of $0.35 per share. This represents a $1.40 dividend on an annualized basis and a dividend yield of 0.97%. The ex-dividend date is Friday, November 30th. HCA Healthcare’s dividend payout ratio (DPR) is presently 21.24%.
WARNING: “Gabelli Funds LLC Has $9.86 Million Position in HCA Healthcare Inc (HCA)” was first posted by WKRB News and is the sole property of of WKRB News. If you are reading this news story on another website, it was illegally stolen and reposted in violation of US and international copyright laws. The legal version of this news story can be accessed at https://www.wkrb13.com/2018/11/11/gabelli-funds-llc-has-9-86-million-position-in-hca-healthcare-inc-hca.html.
HCA Healthcare Profile
HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare Inc (NYSE:HCA).
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.